A549 and H332M human lung cancer cells are known to be resistant to TKIs because of the absence of mutations in EGFR on cell surface, whereas HCC827 human lung cancer cells contain mutated EGFR, thus are sensitive to TKIs. Here, EGFR is linked to lung cancer.